Medifast Names Nicholas Johnson President as CEO Dan Chard Plans 2026 Exit

Reuters01-05
Medifast Names Nicholas Johnson President as CEO Dan Chard Plans 2026 Exit

Medifast Inc. announced that Chairman and CEO Dan Chard plans to step down as CEO in June 2026, while remaining Chairman of the Board. Nicholas Johnson, previously Chief Field Operations Officer, has been appointed President and is expected to become CEO after Chard's departure. Chief Business Operations Officer Tony Tyree has left the company, effective immediately.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medifast Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260105326246) on January 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment